<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="33116">
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on April 10, 2017</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02675543</url>
  </required_header>
  <id_info>
    <org_study_id>Vitreo002</org_study_id>
    <nct_id>NCT02675543</nct_id>
  </id_info>
  <brief_title>Vitreous Inflammation in Standard and Heavy Silicone Oil</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Università degli Studi di Brescia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Università degli Studi di Brescia</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The inflammatory response after prolonged retinal detachment and after vitreoretinal surgery
      has its apex in the development of PVR that occurs when retinal cells are exposed to the
      inflammatory milieu in the humor vitreous.

      This situation is common in complicated retinal detachment, but is amplified after invasive
      surgery and by the use of intraocular tamponades that float over a subtle film of liquid
      where the inflammatory cytokines and growth factors reach the critical concentration over
      the inferior retina.

      Many authors have noted that the heavy tamponade are more prone to cause intraocular
      inflammation compared to standard silicone oil, especially if they remain for several months
      in the eye.

      The purpose of this study is to measure the vitreous concentration of some of the most
      important cytokines involved in the inflammatory vitreal response.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>June 2015</start_date>
  <primary_completion_date type="Actual">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Open Label</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Vitreous Prostaglandin E2 Levels</measure>
    <time_frame>intraoperarive</time_frame>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">70</enrollment>
  <condition>Vitreous Inflammation</condition>
  <arm_group>
    <arm_group_label>Standard silicone oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>after vitreous removal, the vitreous chamber was filled with standard silicone oil (PDMS)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Heavy silicone oil</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>after vitreous removal, the vitreous chamber was filled with heavy silicone oil (Densiron 68)</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Vitreous Tamponade with Silicone Oil</intervention_name>
    <arm_group_label>Standard silicone oil</arm_group_label>
    <arm_group_label>Heavy silicone oil</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patient scheduled for vitrectomy

        Exclusion Criteria:

          -  diabetic retinopathy

          -  uveitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <verification_date>April 2016</verification_date>
  <lastchanged_date>April 12, 2016</lastchanged_date>
  <firstreceived_date>January 25, 2016</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Università degli Studi di Brescia</investigator_affiliation>
    <investigator_full_name>Francesco Semeraro</investigator_full_name>
    <investigator_title>To Compare Vitreous Inflammation in Standard Versus Heavy Silicone Oil</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Inflammation</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
